ATE218365T1 - Stabilisierte mischung auf fibrinogenbasis - Google Patents

Stabilisierte mischung auf fibrinogenbasis

Info

Publication number
ATE218365T1
ATE218365T1 AT98904163T AT98904163T ATE218365T1 AT E218365 T1 ATE218365 T1 AT E218365T1 AT 98904163 T AT98904163 T AT 98904163T AT 98904163 T AT98904163 T AT 98904163T AT E218365 T1 ATE218365 T1 AT E218365T1
Authority
AT
Austria
Prior art keywords
solution
fibrinogen
stabilized
based mixture
arginine
Prior art date
Application number
AT98904163T
Other languages
English (en)
Inventor
Israel Nur
Lilliana Bar
Oded Lieberman
Original Assignee
Omrix Biopharm Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP97101569A external-priority patent/EP0856317A1/de
Application filed by Omrix Biopharm Sa filed Critical Omrix Biopharm Sa
Application granted granted Critical
Publication of ATE218365T1 publication Critical patent/ATE218365T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745Blood coagulation or fibrinolysis factors
    • C07K14/75Fibrinogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10Polypeptides; Proteins
    • A61L24/106Fibrin; Fibrinogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36Blood coagulation or fibrinolysis factors
    • A61K38/363Fibrinogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Surgery (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
AT98904163T 1997-01-31 1998-01-30 Stabilisierte mischung auf fibrinogenbasis ATE218365T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97101569A EP0856317A1 (de) 1997-01-31 1997-01-31 Fibrinogen enthaltende stabilisierte Mischung
PCT/EP1998/000502 WO1998033533A1 (en) 1997-01-31 1998-01-30 A stabilized mixture comprising fibrinogen

Publications (1)

Publication Number Publication Date
ATE218365T1 true ATE218365T1 (de) 2002-06-15

Family

ID=8226433

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98904163T ATE218365T1 (de) 1997-01-31 1998-01-30 Stabilisierte mischung auf fibrinogenbasis

Country Status (13)

Country Link
US (1) US6121232A (de)
JP (1) JP3825055B2 (de)
KR (1) KR100345570B1 (de)
CN (1) CN1182879C (de)
AT (1) ATE218365T1 (de)
AU (1) AU724715B2 (de)
BR (1) BR9807043A (de)
CA (1) CA2279419A1 (de)
DE (1) DE69805772T2 (de)
ES (1) ES2178153T3 (de)
HU (1) HUP0000908A3 (de)
NO (1) NO993709L (de)
PL (1) PL194316B1 (de)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10025001A1 (de) * 2000-05-22 2001-11-29 Aventis Behring Gmbh Gewebekleber mit verbesserten anti-adhäsiven Eigenschaften
US7276235B2 (en) * 1998-11-18 2007-10-02 Zlb Behring Gmbh Tissue glue with improved antiadhesive properties
CN100345591C (zh) * 2003-08-01 2007-10-31 上海新兴医药股份有限公司 耐干热处理的速溶冻干纤维蛋白原制剂
US7186684B2 (en) * 2003-08-07 2007-03-06 Ethicon, Inc. Hemostatic device containing a protein precipitate
CN102091347A (zh) * 2004-10-20 2011-06-15 伊西康公司 可吸收的止血物
US9358318B2 (en) * 2004-10-20 2016-06-07 Ethicon, Inc. Method of making a reinforced absorbable multilayered hemostatic wound dressing
FR2887883B1 (fr) 2005-06-29 2007-08-31 Lab Francais Du Fractionnement Procede de separation des proteines fibrinogene, facteur xiii et colle biologique d'une fraction plasmatique solubilisee et de preparation de concentres lyophilises desdites proteines
ES2485901T3 (es) * 2007-03-22 2014-08-14 The Chemo-Sero-Therapeutic Research Institute Preparación sólida de fibrinógeno
EP2011524A1 (de) 2007-07-02 2009-01-07 Omrix Biopharmaceuticals Ltd. Fibrinleim mit Visualisierungsmittel
EP2034010A1 (de) 2007-08-30 2009-03-11 Omrix Biopharmaceuticals Ltd. Zusammensetzungen zur Reparatur und/oder Behandlung von verletztem Rückenmarksgewebe
US10039865B2 (en) * 2008-09-22 2018-08-07 Omrix Biopharmaceuticals Ltd. Implantable device comprising a substrate pre-coated with stabilized fibrin
JP5805542B2 (ja) * 2009-02-20 2015-11-04 オムリックス・バイオファーマシューティカルズ・リミテッドOmrix Biopharmaceuticals Ltd. 少なくとも2成分の薬物を投与する装置
KR101786786B1 (ko) * 2010-01-28 2017-10-18 옴릭스 바이오파머슈티컬스 리미티드 개선된 피브린 밀봉 방법
IL207586A0 (en) 2010-08-12 2010-12-30 Omrix Biopharmaceuticals Ltd A fibrin based therapeutic preparation and use thereof
CN107389932B (zh) * 2010-09-15 2019-11-22 德比奥法姆国际股份有限公司 用于从含纤维蛋白原的样品中分离目标分子或颗粒的方法
ES2951828T3 (es) 2010-09-23 2023-10-25 Leading Biosciences Inc Administración de inhibidores de serina proteasa al estómago
IL210162A0 (en) 2010-12-21 2011-03-31 Omrix Biopharmaceuticals Viral inactivated platelet extract, use and preparation thereof
IL213375A0 (en) 2011-06-05 2011-07-31 Omrix Biopharmaceuticals Device for spraying fluids in proximity to a surface
US20150064141A1 (en) 2012-04-05 2015-03-05 The Regents Of The University Of California Regenerative sera cells and mesenchymal stem cells
US10130346B2 (en) 2012-07-24 2018-11-20 Omrix Biopharmaceuticals Ltd. Device and method for the application of a curable fluid composition to a bodily organ
EP2934603A1 (de) 2012-12-20 2015-10-28 Omrix Biopharmaceuticals Ltd. Inaktivierte virale biologische mischung
BR112015015703A2 (pt) 2012-12-30 2020-02-04 Omrix Biopharmaceuticals Ltd dispositivo e método para a aplicação de uma composição fluida curável a uma porção de um órgão do corpo
USD754325S1 (en) 2013-06-06 2016-04-19 Omrix Biopharmaceuticals Ltd. Device of a curable fluid composition to a bodily organ
IL230150A0 (en) 2013-12-24 2014-09-30 Omrix Biopharmaceuticals Ltd One-component fibrin glue containing zymogens
IL230151A0 (en) 2013-12-24 2014-09-30 Omrix Biopharmaceuticals Ltd One-component fibrin glue containing a polymerization inhibitor
EP3122349B1 (de) 2014-03-25 2021-12-22 Leading Biosciences, Inc. Zusammensetzungen zur behandlung von autodigestion
IL231792A0 (en) 2014-03-27 2014-08-31 Omrix Biopharmaceuticals Ltd Device and method for the preparation and administration of one-component fibrin glue
IL234246A0 (en) 2014-08-21 2014-11-30 Omrix Biopharmaceuticals Ltd Stabilized thrombin
IL235751A0 (en) 2014-11-18 2015-02-26 Omrix Biopharmaceuticals Ltd An addition to the spray dryer
WO2016079727A1 (en) 2014-11-18 2016-05-26 Omrix Biopharmaceuticals Ltd. Spray-drying apparatus and method of use
CA2976875A1 (en) 2015-02-25 2016-09-01 Omrix Biopharmaceuticals Ltd. Method for purifying and quantifying thrombin and its degradation polypeptides
US10159720B2 (en) 2015-12-08 2018-12-25 Omrix Biopharmaceuticals Ltd Thrombin microcapsules, preparation and uses thereof
IL242984A0 (en) 2015-12-08 2016-02-29 Omrix Biopharmaceuticals Ltd Thrombin microcapsules, their preparation and how to use them
IL242924A0 (en) 2015-12-03 2016-04-21 Omrix Biopharmaceuticals Ltd Syringe system for storing and mixing two ingredients
CN108883086B (zh) 2016-01-11 2021-10-26 恒翼生物医药科技(上海)有限公司 用于治疗和预防粘连及肠梗阻的组合物和方法
JP2017177073A (ja) * 2016-03-31 2017-10-05 テルモ株式会社 塗布具
IL247821A0 (en) 2016-09-14 2017-01-31 Omrix Biopharmaceuticals Ltd Adhesive preparations and their use
CN109081789B (zh) * 2017-06-13 2021-01-01 首都医科大学 氨基正己酰氨基甲环酰氨基正己酰脂肪氨基酸,其合成,活性和应用
IL261190A (en) 2018-08-16 2019-01-31 Omrix Biopharmaceuticals Ltd Stable liquid preparations of thrombin
IL263679A (en) 2018-12-12 2019-03-31 Omrix Biopharmaceuticals Ltd Kits, methods, and compositions for preventing tissue adhesion
WO2020121290A1 (en) 2018-12-12 2020-06-18 Omrix Biopharmaceuticals Ltd. High concentrated protein compositions for preventing tissue adhesion
JP2024534444A (ja) 2021-09-16 2024-09-20 エシコン・インコーポレイテッド 組織経路封止用組成物のためのキット
US20250073313A1 (en) 2021-12-21 2025-03-06 Omrix Biopharmaceuticals Ltd. Highly soluble fibrinogen compositions
US20250108142A1 (en) 2023-09-28 2025-04-03 Ethicon, Inc. Methods for treating leakage from a gastrointestinal site

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT359653B (de) * 1979-02-15 1980-11-25 Immuno Ag Verfahren zur herstellung eines gewebekleb- stoffes
DK475386D0 (da) * 1986-10-03 1986-10-03 Weis Fogh Ulla Sivertsen Fremgangsmaade og apparat til fremstilling af biologiske stoffer
US5278189A (en) * 1990-06-04 1994-01-11 Rath Matthias W Prevention and treatment of occlusive cardiovascular disease with ascorbate and substances that inhibit the binding of lipoprotein (A)
DE69422165T2 (de) * 1993-03-30 2001-10-04 Omrix Biopharmaceuticals S.A., Bruessel/Bruxelles Zweikomponenten-fibrinkleber

Also Published As

Publication number Publication date
NO993709L (no) 1999-09-28
AU724715B2 (en) 2000-09-28
AU6214598A (en) 1998-08-25
PL194316B1 (pl) 2007-05-31
PL334547A1 (en) 2000-03-13
KR100345570B1 (ko) 2002-07-26
ES2178153T3 (es) 2002-12-16
JP3825055B2 (ja) 2006-09-20
HUP0000908A2 (hu) 2000-08-28
US6121232A (en) 2000-09-19
DE69805772D1 (de) 2002-07-11
CA2279419A1 (en) 1998-08-06
KR20000070634A (ko) 2000-11-25
NO993709D0 (no) 1999-07-30
HUP0000908A3 (en) 2001-05-28
BR9807043A (pt) 2000-03-28
JP2000509630A (ja) 2000-08-02
DE69805772T2 (de) 2003-01-30
CN1246069A (zh) 2000-03-01
CN1182879C (zh) 2005-01-05

Similar Documents

Publication Publication Date Title
DE69805772D1 (de) Stabilisierte mischung auf fibrinogenbasis
ES2064439T3 (es) Material adhesivo quirurgico.
DE3751682D1 (de) Infektiöses System zur Arzneimittelabgabe
KR920019371A (ko) 안정화된 인자 ⅷ 제제
DE69522562D1 (de) Eine glucagon enthaltende pharmazeutische zubereitung
NO20002357L (no) Fibrin-tetningsmidler eller -ad-hesiver inneholdende et hyaluronsyrederivat-materiale
DE68901140D1 (de) Waessrige loesung von fettloeslichen wirkstoffen.
FR2591485B1 (fr) Compositions stabilisees contenant l'activateur du plasminogene du tissu humain.
ATE248150T1 (de) Lactam-enthaltende hydroxamsäure-derivate, deren herstellung und deren verwendung als inhibitoren von matrix-metalloproteasen
ES2179910T3 (es) Modificacion cristalina del cdch, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen.
ES2139740T3 (es) Cola de fibrina de dos componentes.
JPS6485096A (en) Hybrid human protein c and biotechnological synthesis thereof
DK1124589T3 (da) Formulering af fibrin-vævsklæber og fremgangsmåde til fremstilling af denne
ATE380202T1 (de) Interaktionssystem zur präsentation und entfernung von substanzen
TW337997B (en) Pharmaceutical preparation containing plasminogen activators
TR199903192T2 (xx) Eritropoetin, de�i�tirilmi� hemoglobin i�eren farmasotik kombine m�stahzarlar.
DE69528170D1 (de) Intrazelluläre verabreichung therapeutischer sustanzenmittels virosomen
AU569896B2 (en) Process for the dissolution of peptides and proteins
ES2170747T3 (es) Analogos superiores de trombomodulina para uso farmaceutico.
AU2851389A (en) Synthetic peptides and mixtures thereof for detecting hiv antibodies
TR199900596T2 (xx) Otoim�n hastal�klara kar�� maddeler olarak proteinlerin kullan�m�.
ATE305612T1 (de) Reporterverbindungen und verfahren zur auffindung von hochspezifische proteaseaktivität
WO2003028654A3 (en) Storage-stable human fibrinogen solutions
CA2234204A1 (en) Novel antibody, renin-active substance containing the same and prorenin assay reagent using the same
DE3889519D1 (de) Glutaminhaltige Peptide, Verfahren zu deren Herstellung und Verwendung.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification